Acquired von Willebrand disease associated with an inhibitor to factor VIII antigen and gastrointestinal telangiectasia
- PMID: 315164
- DOI: 10.1016/0002-9343(79)90267-5
Acquired von Willebrand disease associated with an inhibitor to factor VIII antigen and gastrointestinal telangiectasia
Abstract
A patient with acquired von Willebrand disease and gastrointestinal telangiectasia is described. He presented with the recent onset of spontaneous hemorrhage and demonstrated a prolonged bleeding time, reduced factor VIII coagulant (FVIII:C), and undetectable factor VIII-related antigen (FVIIIR:AG) and ristocetin cofactor (FVIIIR:WF). Following transfusion of cryoprecipitate, there was a smaller than expected immediate increase in FVIII:C, FVIIIR:WF and FVIIIR:AG, with a rapid return to baseline levels and no secondary increase in FVIII:C. An inhibitor could be demonstrated in the patient's plasma which markedly decreased the level of FVIIIR:AG in normal plasma whereas it only weakly decreased the activity of FVIIIR:WF and FVIII:C. The inhibitor was contained in the immunoglobulin G(IgG) fraction of plasma and lacked precipitating properties. This inhibitor demonstrates a specificity not previously seen in spontaneous antifactor VIII antibodies. Our report also demonstrates that ristocetin-induced agglutination of platelets is not always the most sensitive method for detecting an inhibitor in acquired von Willebrand disease.
Similar articles
-
Platelet-collagen interactions: increase in rate of adhesion of fixed washed platelets by factor VIII-related antigen.Blood. 1984 Mar;63(3):495-501. Blood. 1984. PMID: 6421343
-
Selective absence of large forms of factor VIII/von Willebrand factor in acquired von Willebrand's syndrome. Response to transfusion.Blood. 1979 Sep;54(3):600-6. Blood. 1979. PMID: 313821
-
Acquired von Willebrand disease due to inhibitor of human myeloma protein specific for von Willebrand factor.Am J Clin Pathol. 1987 May;87(5):663-8. doi: 10.1093/ajcp/87.5.663. Am J Clin Pathol. 1987. PMID: 3107370
-
Intravenous DDAVP and factor VIII-von Willebrand factor concentrate for the treatment and prophylaxis of bleedings in patients With von Willebrand disease type 1, 2 and 3.Clin Appl Thromb Hemost. 2007 Jan;13(1):14-34. doi: 10.1177/1076029606296399. Clin Appl Thromb Hemost. 2007. PMID: 17164493 Review.
-
Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.Acta Haematol. 2009;121(2-3):128-38. doi: 10.1159/000214853. Epub 2009 Jun 8. Acta Haematol. 2009. PMID: 19506359 Review.
Cited by
-
Acquired von Willebrand disease associated with free lambda light chain monoclonal gammopathy, normal bleeding time and response to prednisone.Postgrad Med J. 1990 Jul;66(777):560-2. doi: 10.1136/pgmj.66.777.560. Postgrad Med J. 1990. PMID: 2120689 Free PMC article.
-
"Angiodysplasia' of the tongue with acquired von Willebrand's disease.Postgrad Med J. 1982 Jan;58(675):37-8. doi: 10.1136/pgmj.58.675.37. Postgrad Med J. 1982. PMID: 6979744 Free PMC article.
-
Acquired von Willebrand's disease.Ir J Med Sci. 1998 Apr-Jun;167(2):81-5. doi: 10.1007/BF02937942. Ir J Med Sci. 1998. PMID: 9638020
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources